Allianz Asset Management
CNST

Allianz Asset Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Allianz Asset Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-358,697
Closed -$12.1M – 2718
2021
Q2 		$12.1M Buy
+358,697
New +$9.14M 0.01% 786

Allianz Asset Management's CNST Position: Q3 2021 in Review

Allianz Asset Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 358,697 shares — an estimated $12.1M sold.

Allianz Asset Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $12.1M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Allianz Asset Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Allianz Asset Management sold 358,697 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $12.1M.
  • Allianz Asset Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Allianz Asset Management's Constellation Pharmaceuticals, Inc. position peaked at $12.1M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Allianz Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.